Core Viewpoint - Lumexa Imaging, a provider of outpatient imaging diagnostic services, has successfully launched on the US stock market with an opening price of $18.8, slightly above its IPO price of $18.5 [1] Company Overview - Lumexa Imaging is headquartered in North Carolina and operates 184 diagnostic centers across 13 states in the US [1] - The company was founded in 2018 by Charlotte Radiology and investment firm Welsh, Carson, Anderson & Stowe, starting with only 20 centers [1] - Lumexa Imaging has expanded through 20 acquisitions and the establishment of 41 new locations [1] Services Offered - The company provides a range of advanced and routine imaging services, including MRI, CT, PET, X-ray, ultrasound, and mammography [1] Network and Partnerships - Lumexa Imaging has developed a diversified referral network, collaborating with over 29,000 healthcare institutions and approximately 100,000 physicians [1] Financial Performance - The company reported a sales figure of $1 billion for the 12 months ending September 30, 2025 [1]

智通财经APP获悉，美国门诊影像诊断服务提供商Lumexa Imaging Holdings于周二公布了其首次公开募 股(IPO)条款。该公司计划以每股17-20美元的价格发行2500万股股票，以筹资4.63亿美元。该公司计划 在纳斯达克上市，股票代码为"LMRI"。 据悉，Lumexa Imaging总部位于北卡罗来纳州，是一家全国性的门诊诊断影像服务提供商，通过全资运 营及与医疗系统合资合作的模式，在美国13个州运营着184家诊疗中心。该公司提供包括磁共振 (MRI)、计算机断层扫描(CT)、正电子发射断层显像(PET)、X光、超声及乳房X光检查在内的各类先进 及常规影像检查服务。该公司由Charlotte Radiology与投资机构Welsh, Carson, Anderson & Stowe于2018 年联合创立，成立之初仅拥有20家中心，后通过20次收购及41家全新门店的开设实现规模扩张。目前， 该公司已构建多元化转诊网络，合作医师覆盖2.9万余家医疗机构，总人数约10万名。数据显示，该公 司在截至2025年9月30日的12个月销售额为10亿美元。 ...